Male Enhancement Procedure Transparency: The Honest Provider Standard

Introduction: Why Transparency Is the New Standard of Care in Male Enhancement

Male cosmetic procedures have increased 500% over the past 25 years, growing from approximately 3% to over 15% of cosmetic patients. The global penile implants market reached $580–$732 million in 2025 and continues expanding at 6–7% annually. This is no longer a fringe market—it is a mainstream medical sector serving millions of men worldwide.

High-earning professionals who apply rigorous due diligence to major financial and medical decisions can immediately detect evasive marketing. The same analytical framework applied to evaluating a merger, selecting legal counsel, or vetting a surgical specialist belongs here. Transparency in male enhancement is not merely an ethical nicety—it is a clinical standard, a legal safeguard, and the single most reliable proxy for provider quality.

The core problem is clear: a market flooded with unregulated products, hidden pricing, and providers who obscure risks creates a landscape where opacity functions as a red flag, not a neutral characteristic. For the professional seeking a solution that actually exists, distinguishing credible providers from harmful ones requires a concrete, verifiable framework.

This article delivers exactly that: a checklist of what genuine male enhancement procedure transparency looks like across pricing, informed consent, risk disclosure, psychological screening, and outcome expectations. This is the professional standard by which any credible provider should be evaluated.

The Transparency Imperative: What the Medical Literature Actually Says

The clinical literature is unambiguous. A 2025 review in Translational Andrology and Urology from the University of South Florida confirmed that prevention of complications “hinges on patient selection, informed consent with expectation management, sterile technique, and adherence to standardized protocols.” Transparency is clinically essential, not optional.

NIH/StatPearls research confirms that informed consent “builds patient confidence, promotes trust in the patient-provider relationship, and safeguards against unethical practices.” Fully informed patients are less likely to encounter adverse outcomes due to misunderstandings.

The professional medical community has formalized these expectations. The Society for the Study of Male Sexual Medicine and Andrology (SMSNA) issued a 2024 position statement providing evidence-based consensus on cosmetic penile enhancement procedures. The British Association of Urological Surgeons (BAUS) published a 2026 consensus document synthesizing literature from 2000–2025 with structured safety recommendations.

Critically, the American Urological Association and Urology Care Foundation maintain that subcutaneous fat injection for girth and suspensory ligament division for length have not been shown to be safe or efficacious. Any provider who does not proactively disclose this official stance is withholding material information.

A 2025 peer-reviewed study in Current Urology found that in most patient cohorts seeking enhancement, patients with below-average penises were extremely rare—the majority had normal-sized penises. This underscores that honest psychological screening and expectation management are not bureaucratic formalities but determinants of patient satisfaction.

For a professional who evaluates risk and return on every major decision, a provider who meets these documented standards is the only defensible choice.

The Honest Provider Checklist: Pricing Disclosure

Male enhancement procedures are elective and cosmetic. Insurance does not cover them, making upfront cost clarity a patient right and a provider obligation.

The cost landscape is substantial. Non-surgical filler treatments can start under $5,000. Surgical options typically range from $10,000–$30,000. Premium filler programs can exceed $200,000 for extensive treatment. Patients deserve to know the full range before committing.

Transparent pricing looks like this in practice:

Free initial consultations
Detailed written cost breakdowns before any procedure
No hidden per-syringe escalation fees
Upfront disclosure of follow-up and revision costs
Available financing options

Red flags of opaque pricing include:

Consultation fees not credited toward procedures
Surprise facility or anesthesia charges
Per-unit pricing revealed only after the patient is in the chair
Vague “starting from” figures with no ceiling disclosed

A transparent provider also addresses lifetime cost. Filler-based treatments typically require maintenance every 18–24 months, while surgical options carry different cost and risk profiles. Honest total-value framing distinguishes providers of integrity.

The absence of published pricing on a website is not automatically disqualifying, but the first consultation must deliver complete cost transparency before any clinical assessment proceeds.

The Honest Provider Checklist: Informed Consent in Practice

Informed consent is a process, not a document. It requires that the patient genuinely understands the procedure, alternatives, risks, benefits, and the right to decline at any point.

A compliant informed consent process includes:

Pre-consultation educational materials
Verbal explanation by the treating physician, not a coordinator
Written documentation in plain language
Opportunity for questions
Confirmation of comprehension

The Asian Journal of Andrology details best practices including full risk/benefit disclosure, alternative treatment discussion, and ensuring patient comprehension before proceeding.

Red flags of inadequate consent:

Rushed paperwork at the appointment
Consent forms presented only on the day of the procedure
Inability to speak directly with the treating physician before signing
Absence of a cooling-off period

Informed consent is both a legal protection and a clinical quality signal. Providers who cut corners on consent are statistically more likely to cut corners elsewhere. Transparent providers proactively explain what the consent form covers rather than simply handing it over for signature.

The Honest Provider Checklist: Risk Acknowledgment and Complication Disclosure

Peer-reviewed research documents that penile enhancement procedures can cause deformity, paradoxical shortening, scarring, granuloma formation, and sexual dysfunction. Any provider who does not disclose these possibilities is operating below the standard of care.

Risk profiles vary by modality. Hyaluronic acid fillers applied with standardized, low-volume protocols generally carry lower complication rates than PMMA, PLA, silicone, or non-medical self-injected materials. Transparent providers explain this distinction explicitly.

The safety data, when honestly presented, builds confidence rather than fear. A 2024 AUA presentation on nearly 500 HA filler patients found all complications were minor (Clavien-Dindo Grade 1–2 only), with 0.42% injection site infections and 0.63% granulomas—no erectile dysfunction or loss of sensitivity was reported.

Honest risk disclosure includes:

Specific complication rates from the provider’s own patient population
Discussion of what happens if a complication occurs
Clarity on who bears the cost of revision or correction

A transparent provider will proactively reference the AUA’s cautionary stance on fat injection and ligament division and explain why the chosen modality differs. Providers who avoid this conversation are concealing material information.

Red flags of inadequate risk disclosure:

Minimizing complications as “extremely rare” without citing data
Failure to discuss the provider’s own complication history
Absence of a documented protocol for managing adverse events

The Honest Provider Checklist: Psychological Screening and Candidacy Assessment

The clinical evidence is clear: approximately 12% of men perceive their penis to be small, yet the majority seeking enhancement have normal-sized penises. The primary driver is psychological, not anatomical, making mental health screening a clinical necessity.

A systematic review in Medicina covering 46 studies recommends interdisciplinary collaboration between urologists, psychologists, sex therapists, and plastic surgeons for comprehensive patient assessment.

Psychological screening in practice includes:

Structured assessment for body dysmorphic disorder (BDD)
Realistic self-perception evaluation
Discussion of underlying motivations
Honest referral to a mental health professional when indicated

A transparent provider openly discusses candidacy disqualification criteria. Patients with BDD, unrealistic expectations, or motivations driven by relationship pressure are not appropriate candidates—and an ethical provider will communicate this clearly.

A provider who screens out inappropriate candidates demonstrates clinical integrity, not revenue avoidance. This is the mark of a practice that prioritizes outcomes over volume.

Red flags of absent psychological screening:

No pre-procedure mental health discussion
No questions about motivation or self-perception
No mechanism for referral

The Honest Provider Checklist: Honest Outcome Expectations

Honest outcome communication includes:

Specific, evidence-based result ranges rather than aspirational maximums
Surgical procedures typically yield 1–2 cm in length and approximately 2.5 cm in girth
Non-surgical filler procedures can produce up to 1–1.5 inches in girth with 80–90% permanence rates

Transparent providers explain that results are achieved incrementally across multiple sessions, not in a single dramatic procedure. Patients who understand this staged treatment approach are more satisfied and less likely to experience regret.

Results vary by anatomy, technique, individual healing response, and baseline measurements. No provider can guarantee a specific outcome. Filler-based results typically last 18–24 months before maintenance; surgical results are more permanent but carry different risk profiles.

The most common patient motivation is improved self-confidence. A transparent provider addresses whether and how the procedure is likely to achieve this psychological goal, not just the physical one.

Red flags of inflated outcome promises:

Before/after galleries featuring only best-case results
Verbal assurances of specific size increases
Failure to discuss the full distribution of outcomes, including patients who experienced minimal change

Recognizing the Unregulated Landscape: Why Provider Selection Is a Safety Decision

The FDA has repeatedly warned consumers about male enhancement products containing hidden, undeclared prescription drugs—as recently as late 2025. Unregulated and counterfeit treatments are “abundantly available on the Internet and US retail settings,” according to a 2025 publication in the Journal of the American Association of Nurse Practitioners.

The minimum provider credentialing standard:

Board-certified physician performing or directly supervising the procedure
Licensed medical facility with hospital-grade sterility protocols
Use of FDA-cleared or medically validated materials
Documented follow-up protocol

Non-medical providers offering filler procedures outside licensed medical settings represent the highest-risk category. A provider who is transparent about credentials, facility standards, material sourcing, and complication management is operating in a regulated and accountable environment.

The same due diligence applied to selecting a financial advisor or surgical specialist should be applied here. When evaluating a male aesthetic medicine specialist, verifying board certification and procedural experience should be the first step.

What the Stoller Medical Group Transparent Standard Looks Like in Practice

Stoller Medical Group exemplifies the transparent provider standard in a real clinical setting. Over 15,000 procedures have been performed by Dr. Roy B. Stoller, a board-certified physician with 25+ years in aesthetic and restorative medicine and five years dedicated specifically to non-surgical male enhancement.

The practice uses Belefil® (hyaluronic acid-based filler), the modality with the strongest safety profile in peer-reviewed literature. Notably, the practice explicitly does not offer surgical penile lengthening due to its higher risk profile—a public, evidence-based decision to decline revenue in favor of patient safety.

The staged treatment protocol reflects realistic expectation management. Incremental sessions rather than single dramatic procedures reduce the risk of overcorrection or asymmetry. Free consultations lower the barrier to asking substantive questions before any commitment is made.

Five accessible locations—Manhattan, Long Island, Albany, Pennsylvania, and Minnesota—support engagement without geographic friction. While specific pricing is not published on the website, the consultation is the appropriate venue for complete cost disclosure, consistent with the transparent standard.

How to Evaluate Any Provider Against the Transparent Standard

The professional’s due diligence checklist:

Pricing: Can the provider give a complete written cost breakdown, including follow-up, revision, and maintenance costs, before any commitment?
Credentials: Is the procedure performed or directly supervised by a board-certified physician? Can credentials be verified independently?
Informed consent: Will there be a substantive conversation with the treating physician before signing any documents? Is there a cooling-off period?
Risk disclosure: Does the provider cite their own complication rates? Do they reference the AUA’s position on specific modalities?
Psychological screening: Does the provider ask about motivations, self-perception, and mental health history? Is there a referral pathway if a procedure is not appropriate?
Outcome expectations: Does the provider give a realistic range of outcomes? Do they explain staged treatment and maintenance requirements?

Opacity on any of these six dimensions is not a minor inconvenience—it is a clinical red flag that should prompt seeking a second opinion or a different provider entirely.

Conclusion: Transparency Is the Standard, Not the Exception

In a market growing at 6–7% annually, with an estimated 322 million men affected by erectile dysfunction and millions more seeking cosmetic enhancement, the difference between a trustworthy provider and a harmful one is measurable. Transparency is the measure.

Pricing disclosure, informed consent, risk acknowledgment, psychological screening, and honest outcome expectations are not aspirational ideals. They are the documented clinical standard endorsed by the AUA, SMSNA, BAUS, and NIH.

Professionals apply rigorous due diligence to every major decision. The same standard belongs here, and the tools to apply it are now available. A provider who cannot or will not meet the transparent standard is not simply less ethical—they are statistically more likely to produce adverse outcomes.

The transparent provider exists. The standard is clear. The decision to proceed, and with whom, is now an informed one.

Ready to Experience the Transparent Standard? Schedule a Free Consultation

Stoller Medical Group / Penis Enlargement New York City invites prospective patients to apply this checklist directly by scheduling a free consultation. The consultation is the appropriate venue to ask every question—pricing, credentials, risk data, psychological fit, and realistic outcomes—before any commitment is made.

With five accessible locations in Manhattan, Long Island, Albany, Pennsylvania, and Minnesota, engagement requires minimal logistical friction. Dr. Stoller’s credentials—board-certified, 25+ years of experience, over 15,000 procedures—make this consultation a worthwhile first step.

Schedule a free consultation today and hold the provider to the standard deserved.